Skip to main content
News Icon

News categories: Publication

Regulation of Innate Immune Responses by Platelets

Platelets have been extensively studied in the context of coagulation and their hemostatic imbalance can lead to conditions as atherosclerotic plaques and thrombosis. Nevertheless, the knowledge regarding the regulation of immune cell types by platelets has been growing exponentially in the past years. Among these biological systems, the innate immunity is remarkably affected by the crosstalk with platelets. This interaction comes from the formation of platelet-leukocyte aggregates, signaling by direct contact or by stimulation of immune cells by soluble factors and microparticles secreted by platelets. These blood components can sense and react danger signals, guiding leukocytes to injury sites and providing a scaffold for the formation of extracellular traps for microbial clearance. Using different mechanisms, platelets have the task to regulate the release of cytokines and chemokines upon sterile or infectious damage, modulate the expression of cell markers and control cell death and survival. Therefore, platelets are more than clotting agents, but critical players within the immune equilibrium for the host. Here we present an understanding about how platelets modulate innate immune cells, as well as a summary of the outcome of this interaction, an important step for therapeutic opportunities and future research on infectious and autoimmune diseases.


Publication

https://www.immunosensation.de/research/publications/pubmed/regulation-of-innate-immune-responses-by-platelets.html


Contact

Prof. Bernardo Franklin

Institute of Innate Immunity

Related news

News Icon

News categories: Publication

Multiple Sclerosis: Potential biomarker linked to progression and brain inflammation identified

Better ways to detect ongoing brain damage in multiple sclerosis (MS) are urgently needed. An international team of scientists, including ImmunoSensation³ member Prof. Anne-Katrin Pröbstel, has identified a molecular circuit that drives brain injury in MS. In a mouse model, blocking the enzyme Bruton's tyrosine kinase prevented harmful clustering of immune cell and brain tissue demage. Patient data revealed the same immune signaling pattern, suggesting strong translational potential for diagnosis. The study was recently published in Nature Immunology.
Full publication
Symbol Image

News categories: Publication

Instructions for building antibodies decoded

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a protein in the myelin layer that surrounds the neurons in the brain. It is believed that these antibodies contribute to the destruction of this protective layer in the brain. Researchers at the University Hospital Bonn (UKB) and the Universities of Basel and Bonn, in collaboration with an international team, have now deciphered the construction plan of the anti-MOG antibodies.
View entry
News Icon

News categories: Publication

A fatal mix-up: how certain gut bacteria drive multiple sclerosis

If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of multiple sclerosis, as researchers at the University of Basel, together with colleagues in Bonn, have shown in trials with mice. However, their results also open up opportunities for treatments that make use of the microbiome. The results have now been published in the journal Gut Microbes.
View entry

Back to the news overview